Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 88

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 88
---
 Loan. The issuances of the 2023 Convertible Notes issued after December 31, 2023, have not been included in the calculation of the pro forma balance sheet as of December 31, 2023. The selected pro forma information has been derived from, and should be read in conjunction with, the unaudited pro forma condensed combined financial information of Profusa appearing elsewhere in this proxy statement/prospectus and the accompanying notes, in the section titled “Unaudited Pro Forma Condensed Combined Financial Information.” The unaudited pro forma condensed combined financial information is derived from, and should be read in conjunction with, the historical financial statements of NorthView and Profusa and related notes included elsewhere in this proxy statement/prospectus. The selected pro forma information has been presented for informational purposes only and is not necessarily indicative of what New Profusa’s financial position or results of operations actually would have been had the Merger and other events contemplated by the Merger Agreement been completed as of the dates indicated. In addition, the selected pro forma information does not purport to project the future financial position or operating results of New Profusa. The following table presents selected pro forma information after giving effect to the Merger and other events contemplated by the Merger Agreement, presented under two scenarios: •Assuming No Redemption: This presentation assumes that no public stockholders of NorthView exercise redemption rights with respect to their public shares for a pro rata share of the funds in the trust account. •Assuming Maximum Redemption: This presentation assumes NorthView’s public shares are redeemed for their pro rata share of the funds in NorthView’s trust account. This scenario gives effect to NorthView’s public share redemptions of 265,222shares excluding redemptions previously made in connection with the Extension, such that the remaining trust balance would be $5,000,001 at the time of the Business Combinations. The Merger Agreement provides that the obligations of Profusa to consummate the Merger are conditioned on, among other things, that as of the Closing, NorthView will have a minimum of $15.0 million in cash. Profusa has conditionally waived the Minimum Cash Amount closing condition, subject to NorthView having sufficient funds to satisfy Nasdaq’s initial listing requirements as of the Closing. 22

The following summarizes the pro forma New Profusa common stock issued and outstanding immediately after the Business Combination, presented under the two redemption scenarios listed:

|                                                                                                   |     | Pro Forma Combined 
       (